Company Monitoring Page for Vivus

latest headlines for company on cafepharma

Arena - Scripts, Ads, Sales Reps
Seeking Alpha
Fri, 03/28/14 - 01:01 pm
Tags:
Arena Pharmaceuticals, drug ads, drug reps, Belviq, Qsymia, Vivus
Vivus: Shares Are Oversold, Pressure Is On To Secure A Commercial Partner And Drive Market Penetration
Seeking Alpha
Wed, 03/26/14 - 04:58 pm
Tags:
Vivus, Qsymia, Orexigen, Contrave, Belviq, Arena Pharmaceuticals
Vivus Announces Review Article Summarizing Cardiovascular Benefit-Risk Profile of Qsymia
Yahoo/Benzinga
Tue, 03/25/14 - 08:04 am
Tags:
Vivus, Qsymia
The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind
Motley Fool
Fri, 03/14/14 - 08:39 am
Tags:
biotech, Sarepta Therapeutics, OncoMed, Vivus, MannKind, Myriad Genetics
Have Anti-Obesity Drug Companies Failed?
Seeking Alpha
Fri, 03/7/14 - 03:56 pm
Tags:
obesity, Arena Pharmaceuticals, Vivus, Orexigen
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data
Yahoo/Zacks.com
Wed, 03/5/14 - 11:46 am
Tags:
InterMune, Esbriet, Alexion, Soliris, Vivus, Qsymia, Regeneron, Eylea
It's Always Darkest Before The Dawn: Why Vivus Could Double In Three Months And Triple In Twelve
Seeking Alpha
Mon, 03/3/14 - 11:51 am
Tags:
Vivus, Qsymia, Stendra
VIVUS' Q4 Loss Shrinks 70% as Licensing Revenue Soars
Motley Fool
Mon, 02/24/14 - 05:39 pm
Tags:
Vivus, earnings
Cheaper Obesity Drugs Available (for Half of Some Americans)
Daily Finance
Mon, 02/24/14 - 05:25 pm
Tags:
obesity, Arena Pharmaceuticals, Eisai, Vivus, Orexigen, Belviq, Qsymia, Contrave
Biotech Showdown: Arena Pharmaceuticals vs. VIVUS Inc.
Motley Fool
Fri, 02/21/14 - 10:44 am
Tags:
obesity, Arena Pharmaceuticals, Vivus, Belviq, Qsymia, Novo Nordisk, Orexigen
Arena Investors Await Strong Sales Data
Seeking Alpha
Mon, 01/27/14 - 08:17 am
Tags:
Arena Pharmaceuticals, Belviq, Eisai, Orexigen, Vivus
VIVUS and Auxilium Announce FDA Acceptance of Supplemental Filing Seeking an Update of Prescribing Information for STENDRA (Avanafil)
Yahoo
Tue, 01/21/14 - 08:10 am
Tags:
erectile dysfunction, Vivus, Auxilium, Stendra, FDA
VIVUS collaborates with Aetna on Qsymia
Yahoo/Fly on the Wall
Tue, 01/14/14 - 08:19 am
Tags:
Vivus, Aetna, Qsymia
New ED Drug: Analysis Of Vivus's Prospects
Seeking Alpha
Thu, 01/9/14 - 08:26 am
Tags:
erectile dysfunction, Vivus, Stendra, Pfizer, Viagra, Cialis, Eli Lilly, Actavis, Auxillium, Bayer
Vivus Scores Insurance Win
Seeking Alpha
Thu, 01/2/14 - 12:37 pm
Tags:
Vivus, Orexigen, obesity, insurance, Caremark, Arena Pharmaceuticals, Qsymia
A Not-So Fat 2013 for This Obesity-Drug Maker
Motley Fool
Thu, 12/26/13 - 01:47 pm
Tags:
obesity, Vivus, Qsymia, Eisai, Belviq, Arena Pharmaceuticals
Sanofi signs on to sell Vivus ED drug in emerging markets
Fierce Pharma
Fri, 12/13/13 - 04:52 pm
Tags:
Vivus, erectile dysfunction, Sanofi, Stendra, Qsymia
The Weight Loss Drug Company Investors Need to Watch Out For
Motley Fool
Fri, 12/13/13 - 08:32 am
Tags:
beloranib, Zafgen, Vivus, Arena Pharmaceuticals
Keep an Eye on AstraZeneca, Avanir, Bristol-Myers Squibb and VIVUS Today
Motley Fool
Thu, 12/12/13 - 11:12 am
Tags:
AstraZeneca, Avair, Bristol-Myers Squibb, Vivus, metreleptin, Nuedexta, Avanafil, Sanofi
Will These Drugmakers Profit From Patient Weight Loss?
Motley Fool
Wed, 12/4/13 - 03:47 pm
Tags:
obesity, Victoza, Novo Nordisk, Contrave, Orexigen, Vivus, Qsymia

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.